Welchol Added To AACE Diabetes Guideline
This article was originally published in PharmAsia News
Daiichi Sankyo announced that Type II diabetes and high cholesterol drug Welchol (colesevelam) has been added to the Road Maps to Achieve Glycemic Control in Type 2 Diabetes Mullitus, a guideline used by physicians and published by the American Association of Clinical Endocrinologists. The company estimates the addition will result in expanded use of the drug. (Click here for more-Japanese language
You may also be interested in...
The approval is based on the results ABRE clinical study, which showed the stent improved patency iliofemoral veins in 88% of cases with a 2% rate of major adverse events.
Reporting its first full quarter of financials since merging with Allergan, AbbVie will be scrutinized for whether its optimistic talk of a quick Botox rebound actually happened.
Generic OTC paracetamol and ibuprofen pack prices are gradually returning to pre-COVID levels, according to market analysts Wavedata. But a second wave could drive prices back up again.